about
The CD46-Jagged1 interaction is critical for human TH1 immunityComplement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell ResponsesComplement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells.DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivoThe Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus InfectionIntracellular complement activation sustains T cell homeostasis and mediates effector differentiation.Complement: coming full circle.CD46 in innate and adaptive immunity: an update.The Th1 life cycle: molecular control of IFN-γ to IL-10 switching.Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus.The "ins and outs" of complement-driven immune responses.Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.Modulation of HLA-G antigens expression in myelomonocytic cells.Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.Immune dysregulation in Alagille syndrome: A new feature of the evolving phenotype.C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation.Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined SignificanceClinical relevance of soluble HLA class I molecules in Waldenstrom MacroglobulinemiaSoluble HLA-G molecules are increased in lymphoproliferative disordersLung macrophages and dendritic cells express HLA-G molecules in pulmonary diseasesMajor histocompatibility complex abnormalities in non-Hodgkin lymphomasDetection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patientsA complement a day keeps the Fox(p3) awayComplement--tapping into new sites and effector systems
P50
Q24301407-CC7E6F7D-86AF-4C05-A73B-3AA73E91E9D7Q33423703-3C98505B-7539-47BE-A5AB-B4CCB2C52708Q33570304-7FBB8496-A292-45D0-AC29-C98F3F62442FQ35084254-88B41796-13C9-4495-8038-E0927082F81CQ36557780-743F5513-EA6D-400C-9F47-692A4D1E4E14Q37397572-83266DA3-1D4D-4565-A90C-142532F805A3Q37623518-1EA9A44D-166D-4483-962B-66618936ED08Q37864688-6CBF95C4-9D19-4FCC-B096-D1176A36C08EQ37870570-ED20F5DB-C33A-4A8A-8467-23D840CF7982Q38818994-B662BB09-DBF6-4A49-A3DA-0A2256A1921AQ38991066-C2BF1AE3-F6E2-4B71-8A1B-E486CC260215Q40522023-A6ED6A3B-FB8B-4CB8-9DC0-92845CD0CF30Q40834770-7733F390-5DB7-41BF-938F-3FCA65C0915BQ40875274-59C41BA0-FD9E-4D15-9C1F-74E2DA260F6AQ41194814-896ED17A-09D1-40FD-B3B3-B3C05ED73781Q47954758-9B6A4940-B654-42A9-807F-A23A6974B4D0Q59413119-7F7D59F0-7EEF-4BBF-B70A-E4BCDAEDBC90Q59607588-8A6DBFF2-8D17-43B3-ADFB-538E053D9B5DQ59607591-52C588D4-9E9D-487B-9776-5D4F9D5756F0Q77578430-26B247ED-BA23-4A6A-892B-612FDBB348EEQ78445429-3DEF4DE5-C4B3-43E1-8F8B-A3CD5EB6DB18Q79259079-2F83FF04-EEE5-4009-857A-8215625ECB0FQ85926258-7B3F5932-F62C-4356-B1DC-495ED4C99F38Q85959086-498DC4FF-D27D-47C3-814C-FAFFEE93991E
P50
description
researcher ORCID ID = 0000-0002-2051-3829
@en
name
Gaelle Le Friec
@ast
Gaelle Le Friec
@en
Gaelle Le Friec
@nl
type
label
Gaelle Le Friec
@ast
Gaelle Le Friec
@en
Gaelle Le Friec
@nl
prefLabel
Gaelle Le Friec
@ast
Gaelle Le Friec
@en
Gaelle Le Friec
@nl
P31
P496
0000-0002-2051-3829